Co-Authors
This is a "connection" page, showing publications co-authored by Andrea Biondi and Franco Locatelli.
Connection Strength
0.442
-
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. Blood. 2017 11 09; 130(19):2146-2149.
Score: 0.184
-
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. J Clin Oncol. 2019 09 01; 37(25):2246-2256.
Score: 0.052
-
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer. 2019 03; 110:86-97.
Score: 0.051
-
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience. Acta Haematol. 2018; 140(2):105-111.
Score: 0.049
-
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018 01 20; 36(3):244-253.
Score: 0.046
-
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms. Br J Cancer. 2017 01; 116(3):335-343.
Score: 0.044
-
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
Score: 0.016